Stoke Therapeutics, Inc. Balance Sheet
STOK / Health Care|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Stoke Therapeutics, Inc. had $418M in total assets and $352M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $84.2M | $128.0M | $191.4M | $113.6M | $144.9M | $287.3M | $222.5M | $105.4M |
| Accounts Receivable | $5.9M | - | - | - | - | - | - | - |
| Current Assets | $305.7M | $232.8M | $215.3M | $244.1M | $229.2M | $293.9M | $226.0M | $106.1M |
| PP&E (Net) | $3.1M | $3.9M | $5.8M | $6.7M | $4.1M | $2.7M | $2.5M | $1.2M |
| Total Assets | $418.4M | $271.6M | $228.3M | $256.1M | $238.9M | $297.9M | $228.8M | $107.5M |
| Current Liabilities | $57.9M | $40.1M | $30.8M | $31.4M | $17.1M | $11.4M | $4.1M | $2.5M |
| Shareholders' Equity | $352.5M | $229.0M | $159.6M | $217.8M | $217.8M | $286.1M | $224.4M | $105.1M |